EnVivo confident in its Alzheimer’s compound
Monday, August 1st, 2011When Eli Lilly stopped developing an Alzheimer’s compound a year ago due to side effects and lack of effectiveness, some experts expressed doubt about a similar drug being developed by Watertown-based EnVivo Pharmaceuticals . Those doubts may have intensified last week, when pharmaceutical giant Lilly released more data on the ... continue reading